Largest COVID-19 Contact Tracing Study Finds Children Key to Spread of Virus
October 1st 2020This is the largest contact tracing study conducted in the world for any disease, analyzing the process of identifying people who came into contact with an infected person, according to a press release.
Read More
NIH to Assess, Expand COVID-19 Testing for Underserved Communities
September 30th 2020The announcement is part of the Rapid Acceleration of Diagnostics (RADx) initiative and the RADx Underserved Populations (RADx-UP) program, which will support 32 institutions across the United States and focus on populations disproportionately affected by the pandemic.
Read More
The results of an additional secondary endpoint from the phase 3 HERO study evaluating oral relugolix in men with advanced prostate cancer showed that relugolix had a similar rate of castration resistance-free survival compared to intravenous leuprolide acetate in men with metastatic disease through 48 weeks.
Read More
Study: Having Pets Linked to Better Mental Health, Reduced Loneliness During COVID-19 Lockdown
September 29th 2020Survey shows that having a pet was linked to maintaining better mental health and reduced loneliness, with 90% of the 6000 participants from the UK saying they had at least 1 pet.
Read More
Study Shows Tethering Together Type 2 Diabetes Drugs Increases Efficacy of Combination Therapy
September 25th 2020Researchers at Duke University have found that the efficacy of a 2-pronged type 2 diabetes (T2D) treatment increases when the drugs are linked by a heat-sensitive tether rather than simply being concurrently administered, according to a press release.
Read More
Study Finds Pembrolizumab Delivers Clinical Benefit in Selected Histotypes of Rare Sarcoma
September 24th 2020The results from a cohort of patients with rare sarcomas in the phase 2 study, presented by professor Jean-Yves Blay, MD, investigated the efficacy and safety of single agent pembrolizumab in rare cancers.
Read More
Study: Certain Immunosuppressing Drugs Do Not Increase Risk for Contracting COVID-19
September 23rd 2020A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.
Read More
Results of Phase 3 Study Find New First-Line Treatment Option for Metastatic Kidney Cancer
September 23rd 2020The CheckMate 9ER trial took 2 drugs used as monotherapies in the second line of therapy, nivolumab and cabozantinib, and combined them for use as a first-line treatment against standard of care, sunitinib.
Read More
Trial Finds Breast Cancer Drug Set to Transform Prostate Cancer Treatment
September 22nd 2020Trial shows that olaparib, a poly ADP ribose polymerase inhibitor that is the first cancer drug to target an inherited genetic fault, can be used successfully to treat prostate cancers with a weakness in the ability to repair damaged DNA.
Read More
Scientists Predict COVID-19 to Become Seasonal Virus in Near Future
September 18th 2020The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.
Read More
Expanding the Role for Technicians in Specialty Pharmacy
September 16th 2020It makes the most sense to get more technicians involved when pharmacies are continuing to grow, since the number of roles that are needed to operate are well suited for technicians, said Jonathan Ogurchak, PharmD, CSP.
Read More
National Study Shows Vaping, Marijuana Use in 2019 Rose in College-Age Adults
September 16th 2020The 2019 survey results from the Monitoring the Future (MTF) study showed that vaping marijuana and nicotine rose sharply in the past 3 years among college age students, or students between 19 and 22 years of age.
Read More
Managing Prescribing Rules, Implementing Real Time Verifications into Workflow During COVID-19
September 16th 2020The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
Read More
FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma
September 14th 2020The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Read More
Clinical Features of COVID-19 Versus Seasonal Influenza A, B in US Children
September 11th 2020A new study published in JAMA suggests that prevention of both coronavirus disease 2019 (COVID-19) and seasonal influenza in US children is sensible and important for the well-being of the population.
Read More
Study: Vaccines Against Respiratory Infections Linked with Fewer Heart Failure Deaths
September 9th 2020Research examines whether immunizations had any link with the risk of heart failure patients dying while in the hospital, since few studies have compared the outcomes of vaccinated and unvaccinated patients.
Read More
Study: High Blood Pressure Telemonitoring May Help Cut Heart Attack, Stroke Rate in Half
September 8th 2020Patients reported their likeness of having support from a trusted health care professional, rapid feedback, and adjustments to their treatment with someone to be accountable to, according to the study authors.
Read More